FinTrust Capital Advisors’s Ginkgo Bioworks DNA Stock Holding History

FinTrust Capital Advisors’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-150	Closed	-$16K	–	1211
2022 Q3	$16K	Hold	150	–	–	﹤0.01%	765
2022 Q2	$18K	Buy	+150	New	+$18.3K	﹤0.01%	754

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

FinTrust Capital Advisors's DNA Position: Q4 2022 in Review

FinTrust Capital Advisors sold out of Ginkgo Bioworks (DNA) in Q4 2022, closing a stake of 150 shares — an estimated $16K sold.

FinTrust Capital Advisors first reported a position in DNA in Q2 2022 and held it in 2 quarters. The position peaked at $18K in Q2 2022. 320 funds tracked by Wall St. Rank hold DNA as of Q4 2022.

FinTrust Capital Advisors reported no remaining Ginkgo Bioworks position as of Q4 2022 after selling out during the quarter.
FinTrust Capital Advisors sold 150 Ginkgo Bioworks shares in Q4 2022, an estimated $16K.
FinTrust Capital Advisors first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 2 quarters.
FinTrust Capital Advisors's Ginkgo Bioworks position peaked at $18K in Q2 2022.
320 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2022.

Based on FinTrust Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.